|
|
||||||||
Biology of Reproduction, Vol 3, 163-168, Copyright © 1970 by Society for the Study of Reproduction
on the Pregnant Rhesus Monkey
1 Fertility Research, The Upjohn Company, Kalamazoo, Michigan 49001 Prostaglandin E2(PGE2) or prostaglandin F2
(PGF2
) was injected subcutaneously
or infused intravenously into pregnant rhesus monkeys. Animals were between day 30
and 127 of pregnancy; pregnancy termination, serum progestin levels, and uterine
contractility were parameters measured to determine efficacy. Subcutaneous injections of
PGF2
or PGE2 terminated pregnancy in 8 of 13 animals when given between day 30
and 41 and beyond day 100 of pregnancy. Intravenous infusion terminated 3 of 7
animals between day 30 and 40 of pregnancy. Progestin levels were usually depressed
within 24-48 hr after the initial administration of prostaglandin, whereas uterine contractility was increased within 20-30 min. Prostaglandin E2 was about 10 times as potent
as PGF2
in causing uterine contractions; intravenous infusion of 0.8 and 8.0 µg/min,
respectively, caused maximal uterine contractions during the latter half of pregnancy.
The realtionship of these compounds to normal pregnant uterine physiology in the
human and rhesus monkey is discussed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |